Technology | Remote Monitoring | June 08, 2016

Wearable Monitor Allows Hospitals Improved Heart Failure Post-discharge Care

System combines wearable biosensor with mobile device-based monitoring to improve patient care post-discharge

Vital Connect, BePATIENT, BeVITAL remote monitoring system, HealthPatch MD

Vital Connect's HealthPatch MD wearable sensor, part of the BeVITAL remote monitoring system.

June 8, 2016 — Vital Connect Inc., developer of wearable biosensor technologies, and BePATIENT, a startup that develops patient-centric digital health solutions, announce the first North American deployment of BeVITAL. The remote patient monitoring solution combines VitalConnect’s U.S. Food and Drug Administration (FDA)-cleared biosensor, HealthPatch MD, with BePATIENT’s web-based solution and associated app, which allows the implementation of personalized healthcare programs accessible through mobile devices and computers.

This spring, BeVITAL will be used in a post-discharge heart failure patient monitoring study at John Muir Medical Center in Walnut Creek and Concord, Calif. Neal White, M.D., heart failure director at John Muir said, “We’re looking forward to seeing how sensor technology and connected patients combine to improve heart failure outcomes for our patients, including reduced readmissions.” The BeVITAL Solution will also be used to follow patients returning home after outpatient surgical procedures at Hospital Infantile De Las Californias in Tijuana, Mexico, in a study run by Scripps Translational Science Institute in San Diego.

The BeVITAL solution can be used to monitor and transmit eight FDA- and CE-cleared biometric data streams from HealthPatch MD directly to practitioners’ smartphones, tablets or computers. In addition, the BeVITAL Solution provides individualized care plans to patients along with meaningful insights to clinicians and researchers.

BeVITAL has already facilitated the post-discharge monitoring of over 80 surgical patients in clinical studies at five hospitals in Europe with two more deployments scheduled for this summer. Phillipe Topart, M.D., a surgeon from the Clinique de l’Anjou in France said, “BeVITAL appears to be a pioneering, innovative solution allowing us to meet the requirements of bariatric surgery follow-up. In general surgery, the vital signs monitoring HealthPatch MD along with the BePATIENT mobile app is a unique tool for remote patient monitoring and detecting post-operative complications. This solution represents a major support tool in complex ambulatory surgery. It seems to me that BeVITAL is a leading connected health solution.”

A patient-centric solution, BeVITAL has been positively received by patients. One patient reported, “The BeVITAL solution gave me the confidence I needed to leave the hospital earlier as I knew my medical team was remotely monitoring my health. It was really easy to use and help me understand what I needed to do after my surgery”.

For more information: www.bepatient.com

Related Content

New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
IBM and Broad Institute Launch AI Initiative for Cardiovascular Disease Risk Prediction
News | Cardiac Diagnostics | February 15, 2019
IBM Watson Health and the Broad Institute of MIT and Harvard are launching a research partnership aimed at developing...
Nearly Half of All U.S. Adults Have Cardiovascular Disease
News | Cardiac Diagnostics | January 31, 2019
January 31, 2019 — Nearly half (48 percent, 121.5 million in 2016) of all adults in the United States have some type
Frequent Red Meat Consumption Triples Levels of Chemical Associated With Heart Disease
News | Cardiac Diagnostics | January 23, 2019
Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical...
Overlay Init